5Indexed trials
drug · Product Intelligence
Gemcitabine
Pipeline Intelligence
Gemcitabine: 5 indexed trials, 2 sponsors; 0 linked Orange Book patents and 9 FDA-linked events where matched.
2Sponsors
0Orange Book patent links
9FDA-linked events
Development evidence
NCT03348904Incyte Corporation · parkinsonsPHASE3
NCT04003636Merck Sharp & Dohme LLC · parkinsonsPHASE3
NCT04191135Merck Sharp & Dohme LLC · parkinsonsPHASE2
NCT05508867Merck Sharp & Dohme LLC · parkinsonsPHASE2
NCT06788912Merck Sharp & Dohme LLC · parkinsonsPHASE2
FDA / patent evidence
Orange Book match found; no listed patent relation was retained for this product match.
Regulatory context
FDA_APPROVALGEMCITABINE HYDROCHLORIDE · 2023-03-07
FDA_APPROVALGEMCITABINE HYDROCHLORIDE · 2018-07-20
FDA_APPROVALGEMCITABINE HYDROCHLORIDE · 2017-12-06
FDA_APPROVALGEMCITABINE HYDROCHLORIDE · 2016-07-28
FDA_APPROVALGEMCITABINE HYDROCHLORIDE · 2016-01-05
FDA_APPROVALGEMCITABINE HYDROCHLORIDE · 2011-07-25
FDA_APPROVALGEMCITABINE HYDROCHLORIDE · 2011-07-25
FDA_APPROVALGEMCITABINE HYDROCHLORIDE · 2011-05-16
FDA_APPROVALGEMCITABINE HYDROCHLORIDE · 2011-05-16
FDA Orange Book coverage is U.S.-specific and is not a substitute for worldwide patent or regulatory review.